Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-09-24

Clinical Trial Update: DOACs for Stroke Prevention Post Ventricular Tachycardia Ablation [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating direct oral anticoagulants for stroke prevention after ventricular tachycardia ablation; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Kansas City Heart Rhythm Institute | Conditions: Ventricular Tachycardia, Premature Ventricular Contraction | Phase 4 | Status: COMPLETED | Results posted: 2021-09-24